erythromycin ethylsuccinate 40 MG/ML Oral Suspension [EryPed]
RxNorm concept 686402, branded drug (sbd). Prescribable name: EryPed 200 MG in 5 mL Oral Suspension.
- RxCUI
- 686402
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/686402 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
EES 40 MG/ML Oral Suspension [EryPed]; EryPed 100 MG per 2.5 ML Oral Suspension; EryPed 200 MG per 5 ML Oral Suspension; EryPed 200 Oral Suspension; EryPed 40 MG/ML Oral Suspension
Related concepts
- erythromycin ethylsuccinate 40 MG/ML (SCDC, consists of)
- erythromycin ethylsuccinate 40 MG/ML [EryPed] (SBDC, consists of)
- Oral Suspension (DF, has dose form)
- EryPed (BN, has ingredient)
- erythromycin ethylsuccinate 40 MG/ML Oral Suspension (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 686402 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/686402 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 686402. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.